Winner Medical Co., Ltd.
SZSE:300888.SZ
38.48 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8,118.609 | 11,351.332 | 8,037.421 | 12,533.946 | 4,574.626 | 3,838.917 | 3,497.581 | 2,559.897 | 1,819.112 | 1,509.871 | 1,271.976 |
| Cost of Revenue
| 4,597.195 | 5,972.801 | 4,028.247 | 5,070.422 | 2,211.927 | 1,951.634 | 1,826.704 | 1,313.07 | 1,052.648 | 990.33 | 887.714 |
| Gross Profit
| 3,521.413 | 5,378.531 | 4,009.174 | 7,463.524 | 2,362.699 | 1,887.284 | 1,670.877 | 1,246.826 | 766.464 | 519.541 | 384.262 |
| Gross Profit Ratio
| 0.434 | 0.474 | 0.499 | 0.595 | 0.516 | 0.492 | 0.478 | 0.487 | 0.421 | 0.344 | 0.302 |
| Reseach & Development Expenses
| 301.107 | 487.584 | 298.162 | 411.383 | 155.193 | 116.564 | 88.628 | 61.075 | 52.792 | 48.25 | 0 |
| General & Administrative Expenses
| 170.8 | 126.077 | 70.928 | 112.737 | -131.254 | -105.732 | -66.896 | 141.268 | 175.945 | 143.048 | 125.733 |
| Selling & Marketing Expenses
| 2,090.493 | 2,050.176 | 1,989.168 | 1,575.164 | 1,355.767 | 1,041.293 | 838.105 | 512.458 | 305.363 | 187.057 | 131.269 |
| SG&A
| 2,377.762 | 2,176.253 | 2,060.096 | 1,687.901 | 1,224.513 | 935.561 | 771.208 | 653.725 | 481.308 | 330.105 | 257.002 |
| Other Expenses
| -190.214 | 521.252 | 346.499 | 370.507 | 345.771 | -3.101 | 31.071 | 10.226 | 18.029 | 13.139 | 7.108 |
| Operating Expenses
| 2,869.083 | 3,185.089 | 2,704.757 | 2,469.79 | 1,725.477 | 1,353.686 | 1,108.02 | 743.131 | 495.921 | 342.49 | 265.648 |
| Operating Income
| 652.33 | 1,976.55 | 1,475.64 | 4,531.737 | 641.771 | 495.714 | 516.122 | 492.064 | 251.269 | 151.384 | 95.85 |
| Operating Income Ratio
| 0.08 | 0.174 | 0.184 | 0.362 | 0.14 | 0.129 | 0.148 | 0.192 | 0.138 | 0.1 | 0.075 |
| Total Other Income Expenses Net
| 95.934 | -57.044 | -12.879 | -29.278 | -3.357 | -33.131 | -45.664 | -1.406 | -6.514 | -21.483 | -17.621 |
| Income Before Tax
| 748.265 | 1,919.506 | 1,462.761 | 4,502.459 | 638.414 | 500.466 | 517.192 | 502.29 | 264.029 | 155.568 | 100.992 |
| Income Before Tax Ratio
| 0.092 | 0.169 | 0.182 | 0.359 | 0.14 | 0.13 | 0.148 | 0.196 | 0.145 | 0.103 | 0.079 |
| Income Tax Expense
| 121.301 | 245.302 | 225.316 | 679.91 | 91.215 | 74.991 | 89.38 | 91.819 | 42.659 | 25.828 | 12.181 |
| Net Income
| 580.403 | 1,650.717 | 1,239.32 | 3,810.413 | 546.294 | 424.685 | 427.205 | 409.641 | 220.54 | 129.059 | 88.139 |
| Net Income Ratio
| 0.071 | 0.145 | 0.154 | 0.304 | 0.119 | 0.111 | 0.122 | 0.16 | 0.121 | 0.085 | 0.069 |
| EPS
| 0.99 | 2.81 | 2.08 | 6.38 | 0.91 | 0.81 | 0.83 | 0.79 | 0.43 | 0.35 | 0.24 |
| EPS Diluted
| 0.99 | 2.81 | 2.08 | 6.38 | 0.91 | 0.81 | 0.83 | 0.79 | 0.43 | 0.35 | 0.24 |
| EBITDA
| 1,247.36 | 2,874.374 | 1,961.116 | 4,940.015 | 764.113 | 639.919 | 639.754 | 514.483 | 310.064 | 206.939 | 122.14 |
| EBITDA Ratio
| 0.154 | 0.253 | 0.244 | 0.394 | 0.167 | 0.167 | 0.183 | 0.201 | 0.17 | 0.137 | 0.096 |